Howard Wealth Management’s VanEck Biotech ETF BBH Stock Holding History

Howard Wealth Management’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Buy	+1,006	New	+$189K	0.08%	152
2024 Q2	–	Sell	-1,218	Closed	-$203K	–	94
2024 Q1	$203K	Hold	1,218	–	–	0.16%	101
2023 Q4	$201K	Buy	+1,218	New	+$187K	0.17%	99
2023 Q1	–	Sell	-1,398	Closed	-$223K	–	110
2022 Q4	$223K	Buy	+1,398	New	+$221K	0.18%	100
2022 Q3	–	Sell	-1,398	Closed	-$203K	–	115
2022 Q2	$203K	Buy	1,398 +30	+2%	+$4.47K	0.22%	58
2022 Q1	$221K	Buy	1,368 +236	+21%	+$38.2K	0.12%	122
2021 Q4	$214K	Buy	1,132 +68	+6%	+$13.1K	0.11%	125
2021 Q3	$215K	Hold	1,064	–	–	0.12%	118
2021 Q2	$214K	Buy	+1,064	New	+$198K	0.12%	123
2020 Q1	–	Sell	-1,014	Closed	-$141K	–	133
2019 Q4	$141K	Buy	+1,014	New	+$133K	0.12%	114

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Howard Wealth Management's BBH Position: Q2 2026 in Review

Howard Wealth Management opened a new position in VanEck Biotech ETF (BBH) in Q2 2026: 1,006 shares worth $204K. The stake represents 0.08% of the portfolio and ranks #152 among its holdings. This is a return to the name: Howard Wealth Management previously reported a position in BBH as recently as Q1 2024.

Howard Wealth Management first reported a position in BBH in Q4 2019 and has held it in 10 quarters since. The position peaked at $223K in Q4 2022. 111 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

Howard Wealth Management held 1,006 shares of VanEck Biotech ETF worth $204K as of Q2 2026.
VanEck Biotech ETF was a new Howard Wealth Management position in Q2 2026.
VanEck Biotech ETF made up 0.08% of Howard Wealth Management's portfolio in Q2 2026, its #152 holding.
Howard Wealth Management first reported a position in VanEck Biotech ETF in Q4 2019 and has held it in 10 quarters since.
Howard Wealth Management's VanEck Biotech ETF position peaked at $223K in Q4 2022.
111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Howard Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.